Literature DB >> 31972259

Modernizing clinical practice guidelines for the American Academy of Dermatology.

Esther E Freeman1, Devon E McMahon2, Matthew Fitzgerald3, Sandy Robinson3, Lindsy Frazer-Green3, Vidhya Hariharan3, Allen McMillen3, Sameer Malik3, Lynn Cornelius4, Hon S Pak5, Terrence A Cronin6, Jeremey S Bordeaux7, Kevin D Cooper7.   

Abstract

The American Academy of Dermatology is modernizing its clinical practice guidelines to be more timely and easily interpretable, while decreasing the influence of conflicts of interest in guideline generation. The main changes include the transition from SORT to GRADE methodology and the requirement that nonconflicted members of the guideline work groups remain nonconflicted throughout the entire guidelines process.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GRADE; conflicts of interest; dermatology; evidence-based medicine; practice guidelines; quality assurance

Mesh:

Year:  2020        PMID: 31972259      PMCID: PMC8815007          DOI: 10.1016/j.jaad.2019.12.075

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature.

Authors:  Mark H Ebell; Jay Siwek; Barry D Weiss; Steven H Woolf; Jeffrey Susman; Bernard Ewigman; Marjorie Bowman
Journal:  Am Fam Physician       Date:  2004-02-01       Impact factor: 3.292

2.  GRADE guidelines: 3. Rating the quality of evidence.

Authors:  Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

3.  Evidence-based medicine: a unified approach.

Authors:  David M Eddy
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Feb       Impact factor: 6.301

Review 4.  What is "quality of evidence" and why is it important to clinicians?

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Gunn E Vist; Yngve Falck-Ytter; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-03

5.  Evaluating the strength of clinical recommendations in the medical literature: GRADE, SORT, and AGREE.

Authors:  Mayra Buainain de Castro Maymone; Stephanie D Gan; Michael Bigby
Journal:  J Invest Dermatol       Date:  2014-10       Impact factor: 8.551

  5 in total
  1 in total

1.  Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease.

Authors:  Esther E Freeman; Devon E McMahon
Journal:  J Am Acad Dermatol       Date:  2020-04-09       Impact factor: 11.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.